{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:26:55Z","timestamp":1792801615574,"version":"4.5.0"},"reference-count":449,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.lfs.2023.122257","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T20:06:04Z","timestamp":1699473964000},"page":"122257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview"],"prefix":"10.1016","volume":"334","author":[{"given":"Eman E.","family":"Alshial","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Idris","family":"Abdulghaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al-Hassan Soliman","family":"Wadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Abdelfatah","family":"Abdellatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada E.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya Muhammed","family":"Suleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Abdellatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6055-9514","authenticated-orcid":false,"given":"Haitham S.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.lfs.2023.122257_bb0005","doi-asserted-by":"crossref","first-page":"13059","DOI":"10.3390\/ijms222313059","article-title":"Mitochondrial biogenesis in neurons: how and where","volume":"22","author":"Cardanho-Ramos","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.lfs.2023.122257_bb0010","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/1873-3468.14298","article-title":"Mitochondria, energy, and metabolism in neuronal health and disease","volume":"596","author":"Trigo","year":"2022","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2023.122257_bb0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.freeradbiomed.2016.11.045","article-title":"Adaptive responses of neuronal mitochondria to bioenergetic challenges: roles in neuroplasticity and disease resistance","volume":"102","author":"Raefsky","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2023.122257_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108698","article-title":"Mitochondrial dysfunction in the development and progression of neurodegenerative diseases","volume":"702","author":"Johnson","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"issue":"8","key":"10.1016\/j.lfs.2023.122257_bb0025","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0006-2952(03)00534-3","article-title":"Mitochondrial dysfunction, apoptotic cell death, and Alzheimer\u2019s disease","volume":"66","author":"Eckert","year":"2003","journal-title":"Biochem. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2023.122257_bb0030","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb0035","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2174\/1570159X14666160229114755","article-title":"Mitochondrial dysfunction in depression","volume":"14","author":"Bansal","year":"2016","journal-title":"Curr. Neuropharmacol."},{"issue":"21","key":"10.1016\/j.lfs.2023.122257_bb0040","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.3390\/ijms232112725","article-title":"Significance of mitochondrial dysfunction in the progression of multiple sclerosis","volume":"23","author":"Blagov","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb0045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.spen.2013.10.001","article-title":"Mitochondrial dysfunction in epilepsy","volume":"20","author":"Khurana","year":"2013","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.lfs.2023.122257_bb0050","doi-asserted-by":"crossref","first-page":"16080","DOI":"10.1038\/nrdp.2016.80","volume":"2","author":"Gorman","year":"2016","journal-title":"Mitochondrial diseases. Nature reviews. Disease primers"},{"key":"10.1016\/j.lfs.2023.122257_bb0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1469-7793.2000.00057.x","article-title":"Mitochondria and calcium: from cell signaling to cell death","volume":"529 Pt 1(Pt 1)","author":"Duchen","year":"2000","journal-title":"J. Physiol."},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb0060","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1873-3468.12964","article-title":"Role of mitochondrial ROS in the brain: from physiology to neurodegeneration","volume":"592","author":"Angelova","year":"2018","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2023.122257_bb0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.cellbio.22.010305.104638","article-title":"Mitochondrial fusion and fission in mammals","volume":"22","author":"Chan","year":"2006","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"6098","key":"10.1016\/j.lfs.2023.122257_bb0070","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1126\/science.1219855","article-title":"Mitochondrial fission, fusion, and stress","volume":"337","author":"Youle","year":"2012","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.lfs.2023.122257_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2015.10.011","article-title":"Mitochondrial fusion\/fission dynamics in neurodegeneration and neuronal plasticity","volume":"90","author":"Bertholet","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"R2","key":"10.1016\/j.lfs.2023.122257_bb0080","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1093\/hmg\/ddp326","article-title":"Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases","volume":"18","author":"Chen","year":"2009","journal-title":"Hum. Mol. Genet."},{"issue":"17","key":"10.1016\/j.lfs.2023.122257_bb0085","doi-asserted-by":"crossref","first-page":"13033","DOI":"10.3390\/ijms241713033","article-title":"Mitochondrial dynamics in neurodegenerative diseases: unraveling the role of fusion and fission processes","volume":"24","author":"Grel","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0090","first-page":"16","article-title":"A review on free radicals and antioxidants","volume":"20","author":"Alkadi","year":"2020","journal-title":"Infect. Disord. Drug Targets"},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cns.12655","article-title":"Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: pathogenesis and treatment","volume":"23","author":"Golpich","year":"2017","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41536-020-00107-x","article-title":"Mitochondrial dysfunction in neurological disorders: exploring mitochondrial transplantation","volume":"5","author":"Norat","year":"2020","journal-title":"NPJ Regen. Med."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb0105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s13534-019-00115-x","article-title":"Photobiomodulation as a treatment for neurodegenerative disorders: current and future trends","volume":"9","author":"Hong","year":"2019","journal-title":"Biomed. Eng. Lett."},{"key":"10.1016\/j.lfs.2023.122257_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.618171","article-title":"Gene therapy for neurodegenerative disease: clinical potential and directions","volume":"14","author":"Zhu","year":"2021","journal-title":"Front. Mol. Neurosci."},{"issue":"Pt 1","key":"10.1016\/j.lfs.2023.122257_bb0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1042\/bj2830041","article-title":"Ca(2+)-dependent changes in the mitochondrial energetics in single dissociated mouse sensory neurons","volume":"283","author":"Duchen","year":"1992","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb0120","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0306-4522(94)00588-V","article-title":"ATP acts as fast neurotransmitter in rat habenula: neurochemical and enzyme cytochemical evidence","volume":"66","author":"Sperl\u00e1gh","year":"1995","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10571-014-0092-3","article-title":"ATP signaling in brain: release, excitotoxicity and potential therapeutic targets","volume":"35","author":"Cisneros-Mejorado","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"issue":"5225","key":"10.1016\/j.lfs.2023.122257_bb0130","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.7543697","article-title":"Regulation of ion channels by ABC transporters that secrete ATP","volume":"269","author":"Al-Awqati","year":"1995","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF03179878","article-title":"Mitochondrial control of neuron death and its role in neurodegenerative disorders","volume":"59","author":"Jord\u00e1n","year":"2003","journal-title":"J. Physiol. Biochem."},{"issue":"7360","key":"10.1016\/j.lfs.2023.122257_bb0140","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature10230","article-title":"A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter","volume":"476","author":"De Stefani","year":"2011","journal-title":"Nature"},{"issue":"7360","key":"10.1016\/j.lfs.2023.122257_bb0145","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nature10234","article-title":"Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter","volume":"476","author":"Baughman","year":"2011","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.lfs.2023.122257_bb0150","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1016\/j.celrep.2017.11.064","article-title":"MICU2 restricts spatial crosstalk between InsP3R and MCU channels by regulating threshold and gain of MICU1-mediated inhibition and activation of MCU","volume":"21","author":"Payne","year":"2017","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0155","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41418-018-0113-8","article-title":"MICU3 is a tissue-specific enhancer of mitochondrial calcium uptake","volume":"26","author":"Patron","year":"2019","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cmet.2014.12.004","article-title":"CCDC90A (MCUR1) is a cytochrome c oxidase assembly factor and not a regulator of the mitochondrial calcium uniporter","volume":"21","author":"Paupe","year":"2015","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0165","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12640-019-00061-7","article-title":"Mitochondria and the brain: bioenergetics and beyond","volume":"36","author":"Belenguer","year":"2019","journal-title":"Neurotox. Res."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb0170","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.neuroimage.2012.02.013","article-title":"Quantitative imaging of energy expenditure in human brain","volume":"60","author":"Zhu","year":"2012","journal-title":"NeuroImage"},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb0175","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.neuron.2008.10.010","article-title":"Mitochondria in neuroplasticity and neurological disorders","volume":"60","author":"Mattson","year":"2008","journal-title":"Neuron"},{"issue":"42","key":"10.1016\/j.lfs.2023.122257_bb0180","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.1523\/JNEUROSCI.1157-19.2019","article-title":"Pleiotropic mitochondria: the influence of mitochondria on neuronal development and disease","volume":"39","author":"Rangaraju","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2023.122257_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101510","article-title":"Iron homeostasis and organismal aging","volume":"72","author":"Zeidan","year":"2021","journal-title":"Ageing Res. Rev."},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb0190","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.neuron.2016.11.025","article-title":"Mitochondria localize to injured axons to support regeneration","volume":"92","author":"Han","year":"2016","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.lfs.2023.122257_bb0195","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00702-015-1398-0","article-title":"Rasagiline and selegiline suppress calcium efflux from mitochondria by PK11195-induced opening of mitochondrial permeability transition pore: a novel anti-apoptotic function for neuroprotection","volume":"122","author":"Wu","year":"2015","journal-title":"J. Neural. Transm. (Vienna, Austria : 1996)"},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb0200","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1073\/pnas.91.4.1309","article-title":"Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis","volume":"91","author":"Virbasius","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0205","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2023.122257_bb0210","doi-asserted-by":"crossref","first-page":"9757201","DOI":"10.1155\/2019\/9757201","article-title":"Mitochondrial dynamics: biogenesis, fission, fusion, and mitophagy in the regulation of stem cell behaviors","volume":"2019","author":"Fu","year":"2019","journal-title":"Stem Cells Int."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0215","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jmb.2019.06.031","article-title":"Quality control in neurons: mitophagy and other selective autophagy mechanisms","volume":"432","author":"Evans","year":"2020","journal-title":"J. Mol. Biol."},{"issue":"10","key":"10.1016\/j.lfs.2023.122257_bb0220","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1089\/ars.2007.1754","article-title":"Mitochondrial dysfunction in aging and Alzheimer\u2019s disease: strategies to protect neurons","volume":"9","author":"Reddy","year":"2007","journal-title":"Antioxid. Redox Signal."},{"issue":"24","key":"10.1016\/j.lfs.2023.122257_bb0225","doi-asserted-by":"crossref","first-page":"16053","DOI":"10.3390\/ijms232416053","article-title":"Mitochondrial dysfunction and therapeutic perspectives in cardiovascular diseases","volume":"23","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.122257_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.703972","article-title":"Targeting mitochondrial-derived reactive oxygen species in T cell-mediated autoimmune diseases","volume":"12","author":"Ch\u00e1vez","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0235","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ddrr.115","article-title":"The role of mitochondrial dysfunction in psychiatric disease","volume":"16","author":"Scaglia","year":"2010","journal-title":"Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.lfs.2023.122257_bb0240","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bcp.2019.03.008","article-title":"Role of mitochondrial dysfunction on rheumatic diseases","volume":"165","author":"Vaamonde-Garc\u00eda","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122257_bb0245","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biopha.2015.07.025","article-title":"Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight","volume":"74","author":"Bhat","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2023.122257_bb0250","doi-asserted-by":"crossref","first-page":"7909380","DOI":"10.1155\/2016\/7909380","article-title":"Is modulation of oxidative stress an answer? The state of the art of redox therapeutic actions in neurodegenerative diseases","volume":"2016","author":"Chiurchi\u00f9","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb0255","first-page":"242","article-title":"Mitochondrial dysfunction during brain aging: role of oxidative stress and modulation by antioxidant supplementation","volume":"2","author":"Chakrabarti","year":"2011","journal-title":"Aging Dis."},{"issue":"8","key":"10.1016\/j.lfs.2023.122257_bb0260","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3390\/molecules24081583","article-title":"Oxidative stress: a key modulator in neurodegenerative diseases","volume":"24","author":"Singh","year":"2019","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0265","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/imr.12286","article-title":"Initiation and perpetuation of NLRP3 inflammasome activation and assembly","volume":"265","author":"Elliott","year":"2015","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb0270","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1111\/brv.12764","article-title":"The mitochondrial permeability transition pore: an evolving concept critical for cell life and death","volume":"96","author":"Morciano","year":"2021","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10863-016-9652-1","article-title":"Physiological roles of the mitochondrial permeability transition pore","volume":"49","author":"Mnatsakanyan","year":"2017","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.lfs.2023.122257_bb0280","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mito.2019.07.003","article-title":"Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling","volume":"49","author":"Wu","year":"2019","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0285","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/mds.25032","article-title":"Pathogenesis of Parkinson\u2019s disease","volume":"28","author":"Hirsch","year":"2013","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb0290","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson\u2019s disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"issue":"14","key":"10.1016\/j.lfs.2023.122257_bb0295","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.lfs.2023.122257_bb0300","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.2174\/1570159X15666171129100944","article-title":"Alpha-synuclein, Proteotoxicity and Parkinson\u2019s disease: search for neuroprotective therapy","volume":"16","author":"Ganguly","year":"2018","journal-title":"Curr. Neuropharmacol."},{"issue":"342","key":"10.1016\/j.lfs.2023.122257_bb0305","doi-asserted-by":"crossref","first-page":"342ra78","DOI":"10.1126\/scitranslmed.aaf3634","article-title":"\u03b1-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease","volume":"8","author":"Di Maio","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.lfs.2023.122257_bb0310","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41419-019-2091-2","article-title":"Mitochondrial damage by \u03b1-synuclein causes cell death in human dopaminergic neurons","volume":"10","author":"Ganjam","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2023.122257_bb0315","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3389\/fnins.2019.01399","article-title":"Alpha-Synuclein physiology and pathology: a perspective on cellular structures and organelles","volume":"13","author":"Bernal-Conde","year":"2020","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0320","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-019-0349-x","article-title":"Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway","volume":"15","author":"Park","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.lfs.2023.122257_bb0325","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2350-12-69","article-title":"Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson\u2019s disease","volume":"12","author":"Clark","year":"2011","journal-title":"BMC Med. Genet."},{"issue":"52","key":"10.1016\/j.lfs.2023.122257_bb0330","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001059","article-title":"PGC-1\u03b1, a potential therapeutic target for early intervention in Parkinson\u2019s disease","volume":"2","author":"Zheng","year":"2010","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb0335","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","article-title":"PARIS (ZNF746) repression of PGC-1\u03b1 contributes to neurodegeneration in Parkinson\u2019s disease","volume":"144","author":"Shin","year":"2011","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.lfs.2023.122257_bb0340","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1038\/emboj.2010.223","article-title":"Inhibition of mitochondrial fusion by \u03b1-synuclein is rescued by PINK1, Parkin and DJ-1","volume":"29","author":"Kamp","year":"2010","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb0345","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archneur.63.5.649","article-title":"Mitochondria in Parkinson disease: back in fashion with a little help from genetics","volume":"63","author":"Muqit","year":"2006","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0350","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009332","article-title":"Mitochondrial biology and Parkinson\u2019s disease","volume":"2","author":"Perier","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"11","key":"10.1016\/j.lfs.2023.122257_bb0355","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.freeradbiomed.2010.08.028","article-title":"Neuroprotection by a mitochondria-targeted drug in a Parkinson\u2019s disease model","volume":"49","author":"Ghosh","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2023.122257_bb0360","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fneur.2019.00122","article-title":"Inflammation, infectious triggers, and Parkinson\u2019s disease","volume":"10","author":"Caggiu","year":"2019","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0365","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.lfs.2023.122257_bb0370","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41556-018-0176-2","article-title":"Mechanisms of mitophagy in cellular homeostasis, physiology and pathology","volume":"20","author":"Palikaras","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.lfs.2023.122257_bb0375","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fneur.2013.00100","article-title":"Parkin- and PINK1-dependent Mitophagy in neurons: will the real pathway please stand up?","volume":"4","author":"Grenier","year":"2013","journal-title":"Front. Neurol."},{"issue":"7722","key":"10.1016\/j.lfs.2023.122257_bb0380","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41586-018-0448-9","article-title":"Parkin and PINK1 mitigate STING-induced inflammation","volume":"561","author":"Sliter","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2023.122257_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2017.06.051","article-title":"Mitochondria in neuroinflammation - multiple sclerosis (MS), leber hereditary optic neuropathy (LHON) and LHON-MS","volume":"710","author":"Bargiela","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2023.122257_bb0390","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.expneurol.2014.02.006","article-title":"Molecular mechanisms linking neuroinflammation and neurodegeneration in MS","volume":"262 Pt A","author":"Ellwardt","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2023.122257_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.705920","article-title":"Metabolic control of smoldering neuroinflammation","volume":"12","author":"Peruzzotti-Jametti","year":"2021","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.lfs.2023.122257_bb0400","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.bbabio.2015.05.015","article-title":"Mitochondrial DNA mutations in neurodegeneration","volume":"1847","author":"Keogh","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.lfs.2023.122257_bb0405","first-page":"813","article-title":"Involvement of mitochondria in neurodegeneration in multiple sclerosis","volume":"83","author":"Kozin","year":"2018","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb0410","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.20736","article-title":"Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients","volume":"59","author":"Dutta","year":"2006","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb0415","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bbadis.2011.01.012","article-title":"Analysis of the mitochondrial proteome in multiple sclerosis cortex","volume":"1812","author":"Broadwater","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"14","key":"10.1016\/j.lfs.2023.122257_bb0420","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1177\/1352458514544537","article-title":"The central role of mitochondria in axonal degeneration in multiple sclerosis","volume":"20","author":"Campbell","year":"2014","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0425","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol."},{"issue":"Pt 7","key":"10.1016\/j.lfs.2023.122257_bb0430","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/brain\/awn105","article-title":"Mitochondrial defects in acute multiple sclerosis lesions","volume":"131","author":"Mahad","year":"2008","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0435","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/path.2582","article-title":"Enhanced number and activity of mitochondria in multiple sclerosis lesions","volume":"219","author":"Witte","year":"2009","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb0440","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.22109","article-title":"Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis","volume":"69","author":"Campbell","year":"2011","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.lfs.2023.122257_bb0445","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn2023","article-title":"Axonal conduction and injury in multiple sclerosis: the role of sodium channels","volume":"7","author":"Waxman","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"Pt 6","key":"10.1016\/j.lfs.2023.122257_bb0450","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/brain\/124.6.1114","article-title":"Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"124","author":"Kornek","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.lfs.2023.122257_bb0455","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1749-6632.2002.tb04446.x","article-title":"Regulation of voltage-dependent sodium channel expression in adrenal chromaffin cells: involvement of multiple calcium signaling pathways","volume":"971","author":"Kobayashi","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"10","key":"10.1016\/j.lfs.2023.122257_bb0460","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S1474-4422(16)30165-X","article-title":"Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities","volume":"15","author":"Macrez","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.lfs.2023.122257_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2015.04.042","article-title":"AMPA receptor activation causes preferential mitochondrial Ca2+ load and oxidative stress in motor neurons","volume":"1616","author":"Joshi","year":"2015","journal-title":"Brain Res."},{"issue":"13","key":"10.1016\/j.lfs.2023.122257_bb0470","doi-asserted-by":"crossref","first-page":"11825","DOI":"10.1074\/jbc.M110.153049","article-title":"Dual-specific phosphatase-6 (Dusp6) and ERK mediate AMPA receptor-induced oligodendrocyte death","volume":"286","author":"Domercq","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0475","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s12013-014-0006-5","article-title":"Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease","volume":"70","author":"Kamat","year":"2014","journal-title":"Cell Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0480","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00401-012-1052-y","article-title":"Reduced expression of PGC-1\u03b1 partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex","volume":"125","author":"Witte","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2023.122257_bb0485","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jns.2009.01.009","article-title":"Impaired regulation of electron transport chain subunit genes by nuclear respiratory factor 2 in multiple sclerosis","volume":"279","author":"Pandit","year":"2009","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.lfs.2023.122257_bb0490","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1177\/1352458517711568","article-title":"In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis","volume":"24","author":"Choi","year":"2018","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0495","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbadis.2009.07.002","article-title":"Is multiple sclerosis a mitochondrial disease?","volume":"1802","author":"Mao","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.lfs.2023.122257_bb0500","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028985","article-title":"Neurodegeneration in progressive multiple sclerosis","volume":"8","author":"Campbell","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb0505","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.cmet.2013.11.005","article-title":"Inflammation-induced alteration of astrocyte mitochondrial dynamics requires autophagy for mitochondrial network maintenance","volume":"18","author":"Motori","year":"2013","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb0510","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12264-015-1545-5","article-title":"Role of autophagy in the pathogenesis of multiple sclerosis","volume":"31","author":"Liang","year":"2015","journal-title":"Neurosci. Bull."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb0515","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1254\/jphs.CPJ04006X","article-title":"Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer\u2019s disease","volume":"97","author":"Takuma","year":"2005","journal-title":"J. Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.lfs.2023.122257_bb0520","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb0525","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ana.410210507","article-title":"Altered metabolic properties of cultured skin fibroblasts in Alzheimer\u2019s disease","volume":"21","author":"Sims","year":"1987","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb0530","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1023\/B:JOBB.0000041764.45552.f3","article-title":"Mitochondrial enzymes and endoplasmic reticulum calcium stores as targets of oxidative stress in neurodegenerative diseases","volume":"36","author":"Gibson","year":"2004","journal-title":"J. Bioenerg. Biomembr."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0535","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JAD-2006-9208","article-title":"Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: on defects in the cytochrome c oxidase complex and aldehyde detoxification","volume":"9","author":"Ohta","year":"2006","journal-title":"J. Alzheimers Dis."},{"issue":"3\u20136","key":"10.1016\/j.lfs.2023.122257_bb0540","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0921-8734(92)90030-S","article-title":"Free radical theory of aging","volume":"275","author":"Harman","year":"1992","journal-title":"Mutat. Res."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0545","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/alz.12683","article-title":"The role of mitochondrial dysfunction in Alzheimer\u2019s disease pathogenesis","volume":"19","author":"Ashleigh","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"18","key":"10.1016\/j.lfs.2023.122257_bb0550","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1111\/bph.14585","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease: role in pathogenesis and novel therapeutic opportunities","volume":"176","author":"Perez Ortiz","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb0555","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/agm2.12217","article-title":"Critical appraisal on mitochondrial dysfunction in Alzheimer's disease","volume":"5","author":"Ahmad","year":"2022","journal-title":"Aging Med."},{"issue":"10","key":"10.1016\/j.lfs.2023.122257_bb0560","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/jnr.25110","article-title":"Targeting mitochondria in the regulation of neurodegenerative diseases: a comprehensive review","volume":"100","author":"Maurya","year":"2022","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0565","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/biomedicines9010063","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease: a biomarker of the future?","volume":"9","author":"Bell","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0570","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41380-022-01631-6","article-title":"Mitophagy in Alzheimer\u2019s disease: molecular defects and therapeutic approaches","volume":"28","author":"Mary","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb0575","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0197-4580(00)00112-3","article-title":"A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients","volume":"21","author":"Maurer","year":"2000","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb0580","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0197-4580(01)00314-1","article-title":"Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer\u2019s disease","volume":"23","author":"Bosetti","year":"2002","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb0585","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/1531-8249(199910)46:4<648::AID-ANA14>3.0.CO;2-X","article-title":"Sleep disorders in children with blindness","volume":"46","author":"Leger","year":"1999","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0590","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbadis.2009.10.006","article-title":"Mitochondrial dysfunction is a trigger of Alzheimer\u2019s disease pathophysiology","volume":"1802","author":"Moreira","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.lfs.2023.122257_bb0595","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.bbabio.2014.02.007","article-title":"Mitochondrial import and degradation of amyloid-\u03b2 peptide","volume":"1837","author":"Pinho","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"2\u20133","key":"10.1016\/j.lfs.2023.122257_bb0600","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12035-010-8109-5","article-title":"Convergence of amyloid-beta and tau pathologies on mitochondria in vivo","volume":"41","author":"Eckert","year":"2010","journal-title":"Mol. Neurobiol."},{"issue":"18","key":"10.1016\/j.lfs.2023.122257_bb0605","doi-asserted-by":"crossref","first-page":"15666","DOI":"10.1074\/jbc.M200887200","article-title":"Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis","volume":"277","author":"Kienlen-Campard","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb0610","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10863-005-6631-3","article-title":"Gradual alteration of mitochondrial structure and function by beta-amyloids: importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release","volume":"37","author":"Aleardi","year":"2005","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.lfs.2023.122257_bb0615","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.brainres.2011.07.052","article-title":"Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer\u2019s disease","volume":"1415","author":"Reddy","year":"2011","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0620","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.biocel.2004.07.009","article-title":"The role of inflammation in Alzheimer\u2019s disease","volume":"37","author":"Tuppo","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"6593","key":"10.1016\/j.lfs.2023.122257_bb0625","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/382716a0","article-title":"Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils","volume":"382","author":"El Khoury","year":"1996","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2023.122257_bb0630","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0165-5728(98)00226-4","article-title":"A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced","volume":"93","author":"Johnstone","year":"1999","journal-title":"J. Neuroimmunol."},{"issue":"9","key":"10.1016\/j.lfs.2023.122257_bb0635","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","article-title":"Mitochondrial abnormalities in Alzheimer\u2019s disease","volume":"21","author":"Hirai","year":"2001","journal-title":"J. Neurosci."},{"issue":"16","key":"10.1016\/j.lfs.2023.122257_bb0640","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM198504183121618","article-title":"Altered calcium uptake in cultured skin fibroblasts from patients with Alzheimer\u2019s disease","volume":"312","author":"Peterson","year":"1985","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb0645","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1568-1637(03)00029-1","article-title":"The calpains in aging and aging-related diseases","volume":"2","author":"Nixon","year":"2003","journal-title":"Ageing Res. Rev."},{"issue":"19","key":"10.1016\/j.lfs.2023.122257_bb0650","doi-asserted-by":"crossref","first-page":"7916","DOI":"10.1073\/pnas.1300677110","article-title":"Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer\u2019s disease and related models","volume":"110","author":"Hedskog","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"21","key":"10.1016\/j.lfs.2023.122257_bb0655","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1038\/emboj.2012.202","article-title":"Upregulated function of mitochondria-associated ER membranes in Alzheimer disease","volume":"31","author":"Area-Gomez","year":"2012","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb0660","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41419-017-0027-2","article-title":"Mitochondria-associated membranes (MAMs) and inflammation","volume":"9","author":"Missiroli","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2023.122257_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113321","article-title":"Mitochondria in Alzheimer\u2019s disease and their potential role in Alzheimer\u2019s proteostasis","volume":"330","author":"Weidling","year":"2020","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0670","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/WOX.0b013e3182439613","article-title":"Oxidative stress and antioxidant defense","volume":"5","author":"Birben","year":"2012","journal-title":"World Allergy Organ. J."},{"issue":"10","key":"10.1016\/j.lfs.2023.122257_bb0675","article-title":"A meta-analysis of oxidative stress markers in depression","volume":"10","author":"Liu","year":"2015","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.lfs.2023.122257_bb0680","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.tips.2016.06.007","article-title":"Targeting oxidative stress in central nervous system disorders","volume":"37","author":"Patel","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2023.122257_bb0685","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jad.2017.06.001","article-title":"The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depression","volume":"233","author":"Kageyama","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"7","key":"10.1016\/j.lfs.2023.122257_bb0690","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.mp.4002055","article-title":"Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression","volume":"13","author":"Goshen","year":"2008","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb0695","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12779","article-title":"The mitochondria-targeted anti-oxidant MitoQ protects against intervertebral disc degeneration by ameliorating mitochondrial dysfunction and redox imbalance","volume":"53","author":"Kang","year":"2020","journal-title":"Cell Prolif."},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb0700","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2174\/1389450120666191017114735","article-title":"Navigating Alzheimer\u2019s disease via chronic stress: the role of glucocorticoids","volume":"21","author":"Sharma","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.lfs.2023.122257_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100972","article-title":"Neuronal autophagy and mitophagy in Parkinson\u2019s disease","volume":"82","author":"Lizama","year":"2021","journal-title":"Mol. Aspects Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0710","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5483\/BMBRep.2008.41.1.011","article-title":"The role of mitochondria in apoptosis","volume":"41","author":"Jeong","year":"2008","journal-title":"BMB Rep."},{"issue":"12","key":"10.1016\/j.lfs.2023.122257_bb0715","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1016\/j.bbamem.2018.10.007","article-title":"Oxidatively stressed mitochondria-mimicking membranes: a molecular insight into their organization during apoptosis","volume":"1860","author":"Dingeldein","year":"2018","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.lfs.2023.122257_bb0720","article-title":"Role of mitochondria in neurodegenerative diseases: from an epigenetic perspective","volume":"9","author":"Xu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0725","doi-asserted-by":"crossref","first-page":"H206","DOI":"10.1152\/ajpheart.00714.2017","article-title":"A microRNA\u2019s journey to the center of the mitochondria","volume":"315","author":"Macgregor-Das","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb0730","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4103\/1673-5374.293149","article-title":"Temporal changes in inflammatory mitochondria-enriched microRNAs following traumatic brain injury and effects of miR-146a nanoparticle delivery","volume":"16","author":"Wang","year":"2021","journal-title":"Neural Regen. Res."},{"issue":"7","key":"10.1016\/j.lfs.2023.122257_bb0735","first-page":"532","article-title":"Epilepsy in mitochondrial diseases-current state of knowledge on aetiology and treatment","volume":"8","author":"Wes\u00f3\u0142-Kucharska","year":"2021","journal-title":"Children (Basel, Switzerland)"},{"key":"10.1016\/j.lfs.2023.122257_bb0740","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fncel.2016.00136","article-title":"Status epilepticus in immature rats is associated with oxidative stress and mitochondrial dysfunction","volume":"10","author":"Folbergrov\u00e1","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.lfs.2023.122257_bb0745","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2478\/v10078-012-0049-x","article-title":"A review on the effects of soccer small-sided games","volume":"33","author":"Aguiar","year":"2012","journal-title":"J. Hum. Kinet."},{"issue":"9","key":"10.1016\/j.lfs.2023.122257_bb0750","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1007\/s12035-018-0924-0","article-title":"Effect of resveratrol on oxidative stress and mitochondrial dysfunction in immature brain during epileptogenesis","volume":"55","author":"Folbergrov\u00e1","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"11","key":"10.1016\/j.lfs.2023.122257_bb0755","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.3390\/ijms18112365","article-title":"Metabolic dysfunction and oxidative stress in epilepsy","volume":"18","author":"Pearson-Smith","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0760","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00401-015-1481-5","article-title":"Infections, inflammation and epilepsy","volume":"131","author":"Vezzani","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.lfs.2023.122257_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106824","article-title":"Transient receptor potential melastatin 2 contributes to neuroinflammation and negatively regulates cognitive outcomes in a pilocarpine-induced mouse model of epilepsy","volume":"87","author":"Hu","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"12","key":"10.1016\/j.lfs.2023.122257_bb0770","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/sj.jcbfm.9600149","article-title":"Epilepsy and apoptosis pathways","volume":"25","author":"Henshall","year":"2005","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.lfs.2023.122257_bb0775","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.695380","article-title":"Astrocytic Ca 2+ signaling in epilepsy","volume":"15","author":"Heuser","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.lfs.2023.122257_bb0780","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/B978-0-444-63326-2.00005-3","article-title":"Mechanisms underlying epilepsies associated with sodium channel mutations","volume":"213","author":"Steinlein","year":"2014","journal-title":"Prog. Brain Res."},{"issue":"17","key":"10.1016\/j.lfs.2023.122257_bb0785","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.3390\/cells11172621","article-title":"Molecular mechanism and regulation of autophagy and its potential role in epilepsy","volume":"11","author":"Zhu","year":"2022","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.lfs.2023.122257_bb0790","first-page":"182","article-title":"Progress of autophagy in epilepsy research","volume":"10","author":"Mo","year":"2022","journal-title":"J. Biosci. Med."},{"key":"10.1016\/j.lfs.2023.122257_bb0795","article-title":"The mechanism of mitochondrial autophagy regulating CME in","author":"Zhou","year":"2022","journal-title":"epilepsy"},{"key":"10.1016\/j.lfs.2023.122257_bb0800","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.885500","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease: from mechanistic insights to therapy","volume":"14","author":"Gao","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.lfs.2023.122257_bb0805","first-page":"S155","article-title":"Mitochondrial therapies for Parkinson\u2019s disease","volume":"25 Suppl 1(Suppl 1)","author":"Thomas","year":"2010","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb0810","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1042\/BST20170501","article-title":"Mitochondrial abnormalities in Parkinson\u2019s disease and Alzheimer\u2019s disease: can mitochondria be targeted therapeutically?","volume":"46","author":"Macdonald","year":"2018","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.lfs.2023.122257_bb0815","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuint.2014.12.012","article-title":"Changes in the mitochondrial antioxidant systems in neurodegenerative diseases and acute brain disorders","volume":"88","author":"Ruszkiewicz","year":"2015","journal-title":"Neurochem. Int."},{"issue":"8","key":"10.1016\/j.lfs.2023.122257_bb0820","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bbadis.2013.09.007","article-title":"Mitochondria-targeted antioxidants for treatment of Parkinson\u2019s disease: preclinical and clinical outcomes","volume":"1842","author":"Jin","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.lfs.2023.122257_bb0825","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/biomedicines9080918","article-title":"Oxidative stress, mitochondrial dysfunction, and neuroprotection of polyphenols with respect to resveratrol in Parkinson\u2019s disease","volume":"9","author":"Kung","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb0830","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.21037\/apm-19-426","article-title":"Protective effects of resveratrol liposomes on mitochondria in substantia nigra cells of parkinsonized rats","volume":"10","author":"Chen","year":"2021","journal-title":"Ann. Palliat. Med."},{"issue":"7","key":"10.1016\/j.lfs.2023.122257_bb0835","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1074\/jbc.M009093200","article-title":"Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties","volume":"276","author":"Kelso","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb0840","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s12640-022-00501-x","article-title":"Contributions and limitations of mitochondria-targeted and non-targeted antioxidants in the treatment of parkinsonism: an updated review","volume":"40","author":"Banerjee","year":"2022","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.lfs.2023.122257_bb0845","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mcn.2012.11.011","article-title":"Mitochondria targeted therapeutic approaches in Parkinson\u2019s and Huntington\u2019s diseases","volume":"55","author":"Chaturvedi","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0850","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41531-022-00402-y","article-title":"Mitophagy and reactive oxygen species interplay in Parkinson\u2019s disease","volume":"8","author":"Xiao","year":"2022","journal-title":"NPJ Parkinson\u2019s Dis."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0855","doi-asserted-by":"crossref","first-page":"16461","DOI":"10.1038\/s41598-019-52839-6","article-title":"Pioglitazone modulates the vascular contractility in hypertension by interference with ET-1 pathway","volume":"9","author":"Palacios-Ram\u00edrez","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.122257_bb0860","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fnagi.2020.00089","article-title":"Mitochondrial dysfunction and Parkinson\u2019s disease-near-infrared photobiomodulation as a potential therapeutic strategy","volume":"12","author":"Foo","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb0865","first-page":"818","article-title":"Therapeutic effect of near infrared (NIR) light on Parkinson\u2019s disease models","volume":"4","author":"Quirk","year":"2012","journal-title":"Front. Biosci. (Elite Ed.)"},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0870","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1515\/revneuro-2012-0086","article-title":"Red\/near-infrared irradiation therapy for treatment of central nervous system injuries and disorders","volume":"24","author":"Fitzgerald","year":"2013","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.lfs.2023.122257_bb0875","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.965788","article-title":"Transcranial near-infrared light in treatment of neurodegenerative diseases","volume":"13","author":"Nizamutdinov","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122257_bb0880","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.615461","article-title":"Targeting mitochondrial impairment in Parkinson\u2019s disease: challenges and opportunities","volume":"8","author":"Prasuhn","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.lfs.2023.122257_bb0885","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.trsl.2015.12.003","article-title":"Allogeneic\/xenogeneic transplantation of peptide-labeled mitochondria in Parkinson\u2019s disease: restoration of mitochondria functions and attenuation of 6-hydroxydopamine-induced neurotoxicity","volume":"170","author":"Chang","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.lfs.2023.122257_bb0890","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.653322","article-title":"Mitochondria donation by mesenchymal stem cells: current understanding and mitochondria transplantation strategies","volume":"9","author":"Gomzikova","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb0895","doi-asserted-by":"crossref","first-page":"10597","DOI":"10.1038\/s41598-021-90094-w","article-title":"Intranasal delivery of mitochondria for treatment of Parkinson\u2019s disease model rats lesioned with 6-hydroxydopamine","volume":"11","author":"Chang","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb0900","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.celrep.2014.05.027","article-title":"Long-term health of dopaminergic neuron transplants in Parkinson\u2019s disease patients","volume":"7","author":"Hallett","year":"2014","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.lfs.2023.122257_bb0905","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: a review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb0910","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20182417","article-title":"Mesenchymal stem cells and their mitochondrial transfer: a double-edged sword","volume":"39","author":"Li","year":"2019","journal-title":"Biosci. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb0915","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/molecules23030687","article-title":"Miro1 enhances mitochondria transfer from multipotent mesenchymal stem cells (MMSC) to neural cells and improves the efficacy of cell recovery","volume":"23","author":"Babenko","year":"2018","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"11","key":"10.1016\/j.lfs.2023.122257_bb0920","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3390\/genes12111840","article-title":"Gene therapeutic approaches for the treatment of mitochondrial dysfunction in Parkinson\u2019s disease","volume":"12","author":"Prasuhn","year":"2021","journal-title":"Genes"},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0925","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4103\/1673-5374.317957","article-title":"Deciphering the role of PGC-1\u03b1 in neurological disorders: from mitochondrial dysfunction to synaptic failure","volume":"17","author":"Panes","year":"2022","journal-title":"Neural Regen. Res."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb0930","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/febs.13175","article-title":"New insights into PGC-1 coactivators: redefining their role in the regulation of mitochondrial function and beyond","volume":"282","author":"Villena","year":"2015","journal-title":"FEBS J."},{"issue":"10","key":"10.1016\/j.lfs.2023.122257_bb0935","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1089\/ars.2010.3799","article-title":"Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control","volume":"14","author":"Narendra","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0940","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00401-011-0902-3","article-title":"Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson\u2019s disease","volume":"123","author":"Pilsl","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb0945","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3390\/pharmaceutics14061252","article-title":"CRISPR-Cas9-based technology and its relevance to gene editing in Parkinson\u2019s disease","volume":"14","author":"Rahman","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2023.122257_bb0950","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neurobiolaging.2017.06.025","article-title":"Transcranial low-level laser therapy improves brain mitochondrial function and cognitive impairment in D-galactose-induced aging mice","volume":"58","author":"Salehpour","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb0955","first-page":"105","article-title":"Mechanism and adverse effects of multiple sclerosis drugs: a review article. Part 2","volume":"11","author":"Rafiee Zadeh","year":"2019","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122257_bb0960","volume":"65","author":"Singh","year":"2021","journal-title":"Pharmacological advances in mitochondrial therapy. EBioMedicine"},{"issue":"24","key":"10.1016\/j.lfs.2023.122257_bb0965","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020078118","article-title":"Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis","volume":"118","author":"Patergnani","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"19","key":"10.1016\/j.lfs.2023.122257_bb0970","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010627","article-title":"Effect of photobiomodulation treatment in the sublingual, radial artery region, and along the spinal column in individuals with multiple sclerosis: protocol for a randomized, controlled, double-blind, clinical trial","volume":"97","author":"da Silva","year":"2018","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.lfs.2023.122257_bb0975","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.freeradbiomed.2012.08.003","article-title":"Photobiomodulation by low-power laser irradiation attenuates A\u03b2-induced cell apoptosis through the Akt\/GSK3\u03b2\/\u03b2-catenin pathway","volume":"53","author":"Liang","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"42","key":"10.1016\/j.lfs.2023.122257_bb0980","doi-asserted-by":"crossref","first-page":"40917","DOI":"10.1074\/jbc.M303034200","article-title":"Low energy visible light induces reactive oxygen species generation and stimulates an increase of intracellular calcium concentration in cardiac cells","volume":"278","author":"Lavi","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0985","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/08916934.2015.1124425","article-title":"Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis","volume":"49","author":"Gon\u00e7alves","year":"2016","journal-title":"Autoimmunity"},{"key":"10.1016\/j.lfs.2023.122257_bb0990","doi-asserted-by":"crossref","DOI":"10.34172\/jlms.2021.88","article-title":"The role of Low-level laser therapy in the treatment of multiple sclerosis: a review study","volume":"12","author":"Hossein-Khannazer","year":"2021","journal-title":"J. Lasers Med. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb0995","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/lsm.20202","article-title":"Low power laser irradiation alters gene expression of olfactory ensheathing cells in vitro","volume":"37","author":"Byrnes","year":"2005","journal-title":"Lasers Surg. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1000","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00415-020-10362-z","article-title":"Rituximab for the treatment of multiple sclerosis: a review","volume":"269","author":"Chisari","year":"2022","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1005","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.intimp.2007.12.007","article-title":"Low-level laser therapy decreases levels of lung neutrophils anti-apoptotic factors by a NF-kappaB dependent mechanism","volume":"8","author":"Aimbire","year":"2008","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.lfs.2023.122257_bb1010","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/lsm.20371","article-title":"Effects of low-level laser therapy (LLLT) on the nuclear factor (NF)-kappaB signaling pathway in traumatized muscle","volume":"38","author":"Rizzi","year":"2006","journal-title":"Lasers Surg. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1423-0127-16-4","article-title":"Molecular mechanisms of cell proliferation induced by low power laser irradiation","volume":"16","author":"Gao","year":"2009","journal-title":"J. Biomed. Sci."},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb1020","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00415-003-1041-0","article-title":"Nitric oxide as an activity marker in multiple sclerosis","volume":"250","author":"Acar","year":"2003","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1025","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/135245859800400323","article-title":"The potential role of nitric oxide in multiple sclerosis","volume":"4","author":"Giovannoni","year":"1998","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb1030","first-page":"183","article-title":"Application of laser radiation and magnetostimulation in therapy of patients with multiple sclerosis","volume":"38","author":"Kubsik","year":"2016","journal-title":"NeuroRehabilitation"},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230551","article-title":"Effects of photobiomodulation on interleukin-10 and nitrites in individuals with relapsing-remitting multiple sclerosis - randomized clinical trial","volume":"15","author":"Silva","year":"2020","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb1040","first-page":"5479","article-title":"Could phototherapy reverse visual deficits in patients with relapsing-remitting multiple sclerosis","volume":"3","author":"Essa","year":"2015","journal-title":"J. Med. Sci. Clin. Res."},{"issue":"5850","key":"10.1016\/j.lfs.2023.122257_bb1045","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/295605a0","article-title":"Mitochondrial transformation of mammalian cells","volume":"295","author":"Clark","year":"1982","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb1050","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(88)90423-0","article-title":"Injection of mitochondria into human cells leads to a rapid replacement of the endogenous mitochondrial DNA","volume":"52","author":"King","year":"1988","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb1055","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1023\/A:1018431316831","article-title":"Mitochondria transfer into mouse ova by microinjection","volume":"6","author":"Pinkert","year":"1997","journal-title":"Transgenic Res."},{"key":"10.1016\/j.lfs.2023.122257_bb1060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40035-019-0158-8","article-title":"Current progress of mitochondrial transplantation that promotes neuronal regeneration","volume":"8","author":"Chang","year":"2019","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1065","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jtcvs.2017.02.018","article-title":"Autologous mitochondrial transplantation for dysfunction after ischemia-reperfusion injury","volume":"154","author":"Emani","year":"2017","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb1070","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10616-019-00302-9","article-title":"Mitochondrial transplantation as a potential and novel master key for treatment of various incurable diseases","volume":"71","author":"Roushandeh","year":"2019","journal-title":"Cytotechnology"},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1075","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.3390\/ijms23042245","article-title":"Promising treatment for multiple sclerosis: mitochondrial transplantation","volume":"23","author":"Picone","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001166","article-title":"Neural stem cells traffic functional mitochondria via extracellular vesicles","volume":"19","author":"Peruzzotti-Jametti","year":"2021","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1085","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12967-019-1893-4","article-title":"Mesenchymal stem cell therapy targeting mitochondrial dysfunction in acute kidney injury","volume":"17","author":"Zhao","year":"2019","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-90115-8","article-title":"Mesenchymal stromal cell mitochondrial transfer to human induced T-regulatory cells mediates FOXP3 stability","volume":"11","author":"Do","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a029025","article-title":"Effector t cells in multiple sclerosis","volume":"8","author":"Kaskow","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"10","key":"10.1016\/j.lfs.2023.122257_bb1100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206140","article-title":"BDNF rs6265 polymorphism methylation in multiple sclerosis: a possible marker of disease progression","volume":"13","author":"Nociti","year":"2018","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1105","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1021\/acs.molpharmaceut.6b01093","article-title":"Amelioration of experimental autoimmune encephalomyelitis in mice by interferon-beta gene therapy, using a long-term expression plasmid vector","volume":"14","author":"Hamana","year":"2017","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1110","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijpharm.2017.12.010","article-title":"Safe and effective interferon-beta gene therapy for the treatment of multiple sclerosis by regulating biological activity through the design of interferon-beta-galectin-9 fusion proteins","volume":"536","author":"Hamana","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2023.122257_bb1115","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/696738","article-title":"Gene therapy of multiple sclerosis using interferon \u03b2-secreting human bone marrow mesenchymal stem cells","volume":"2013","author":"Ryu","year":"2013","journal-title":"Biomed. Res. Int."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1120","first-page":"155","article-title":"FOXP3 gene expression in multiple sclerosis patients pre- and post mesenchymal stem cell therapy","volume":"10","author":"Mohajeri","year":"2011","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1125","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ana.10858","article-title":"Gene therapy in a murine model for clinical application to multiple sclerosis","volume":"55","author":"Weiner","year":"2004","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ymthe.2017.09.001","article-title":"Gene therapy-induced antigen-specific Tregs inhibit neuro-inflammation and reverse disease in a mouse model of multiple sclerosis","volume":"26","author":"Keeler","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2023.122257_bb1135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.mehy.2017.09.017","article-title":"Interleukin 35 and hepatocyte growth factor; as a novel combined immune gene therapy for multiple sclerosis disease","volume":"109","author":"Moghadam","year":"2017","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.lfs.2023.122257_bb1140","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3389\/fimmu.2018.00873","article-title":"Interleukin-27 gene therapy prevents the development of autoimmune encephalomyelitis but fails to attenuate established inflammation due to the expansion of CD11b +gr-1 + myeloid cells","volume":"9","author":"Zhu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2023.122257_bb1145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2013.07.060","article-title":"48. Neuropeptides as cell gene therapy in experimental autoimmune encephalomyelitis","volume":"32","author":"Ganea","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2003.12.013","article-title":"A novel retroviral gene therapy approach to inhibit specific antibody production and suppress experimental autoimmune encephalomyelitis induced by MOG and MBP","volume":"111","author":"Xu","year":"2004","journal-title":"Clin. Immunol. (Orlando, Fla.)"},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb1155","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2174\/1566523220666200306092556","article-title":"Gene therapy approaches in an autoimmune demyelinating disease: multiple sclerosis","volume":"19","author":"Islam","year":"2020","journal-title":"Curr. Gene Ther."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1160","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12035-012-8271-z","article-title":"Mitochondrial dysfunction--a pharmacological target in Alzheimer\u2019s disease","volume":"46","author":"Eckert","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2023.122257_bb1165","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1749-6632.2001.tb03654.x","article-title":"Antihistamine agent Dimebon as a novel neuroprotector and a cognition enhancer","volume":"939","author":"Bachurin","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb1170","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s10517-019-04612-y","article-title":"Wave-like dose-dependence of the stimulating effects of Dimebon on cognition in a wide dose range","volume":"167","author":"Vasilieva","year":"2019","journal-title":"Bull. Exp. Biol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb1175","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JAD-2010-100174","article-title":"Dimebon (latrepirdine) enhances mitochondrial function and protects neuronal cells from death","volume":"21","author":"Zhang","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1180","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12035-021-02612-6","article-title":"Recent advances in molecular pathways and therapeutic implications targeting mitochondrial dysfunction for Alzheimer\u2019s disease","volume":"59","author":"Dhapola","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1185","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbadis.2012.07.009","article-title":"The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of Parkinson\u2019s disease","volume":"1832","author":"Solesio","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"44","key":"10.1016\/j.lfs.2023.122257_bb1190","doi-asserted-by":"crossref","first-page":"15703","DOI":"10.1523\/JNEUROSCI.0552-11.2011","article-title":"The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer\u2019s disease","volume":"31","author":"McManus","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2023.122257_bb1195","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2019.103409","article-title":"The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice","volume":"101","author":"Young","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb1200","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.phrs.2007.09.011","article-title":"Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761)","volume":"56","author":"Abdel-Kader","year":"2007","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1205","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s13311-019-00767-8","article-title":"Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders","volume":"16","author":"Singh","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.lfs.2023.122257_bb1210","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146730","article-title":"EGb761 ameliorates cell necroptosis by attenuating RIP1-mediated mitochondrial dysfunction and ROS production in both in vivo and in vitro models of Alzheimer\u2019s disease","volume":"1736","author":"Tu","year":"2020","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.lfs.2023.122257_bb1215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012845","article-title":"Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer\u2019s disease","volume":"5","author":"Ma","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.lfs.2023.122257_bb1220","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.nbd.2015.03.014","article-title":"mTOR signaling in aging and neurodegeneration: at the crossroad between metabolism dysfunction and impairment of autophagy","volume":"84","author":"Perluigi","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"Pt 1","key":"10.1016\/j.lfs.2023.122257_bb1225","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/brain\/awq341","article-title":"Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer\u2019s disease ameliorates amyloid pathologies and memory deficits","volume":"134","author":"Yang","year":"2011","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb1230","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/jnc.13037","article-title":"Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD","volume":"133","author":"Tramutola","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2023.122257_bb1235","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-018-0133-9","article-title":"Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of down syndrome","volume":"7","author":"Tramutola","year":"2018","journal-title":"Transl. Neurodegener."},{"issue":"17","key":"10.1016\/j.lfs.2023.122257_bb1240","doi-asserted-by":"crossref","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","article-title":"Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and tau: effects on cognitive impairments","volume":"285","author":"Caccamo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.122257_bb1245","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101162","article-title":"Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: focus on HNE-modified proteins in a mouse model of down syndrome","volume":"23","author":"Di Domenico","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2023.122257_bb1250","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1042\/bse0470069","article-title":"Regulation of mitochondrial biogenesis","volume":"47","author":"Jornayvaz","year":"2010","journal-title":"Essays Biochem."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1255","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/156720209787466019","article-title":"Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection","volume":"6","author":"Pall\u00e0s","year":"2009","journal-title":"Curr. Neurovasc. Res."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1260","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.bbrc.2013.05.025","article-title":"Resveratrol improves learning and memory in normally aged mice through microRNA-CREB pathway","volume":"435","author":"Zhao","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"16","key":"10.1016\/j.lfs.2023.122257_bb1265","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1212\/WNL.0000000000002035","article-title":"A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease","volume":"85","author":"Turner, R. S., Thomas, R. G., Craft, S., van Dyck, C. H., Mintzer, J., Reynolds, B. A., Brewer, J. B., Rissman, R. A., Raman, R., Aisen, P. S., & Alzheimer's Disease Cooperative Study","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.lfs.2023.122257_bb1270","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jphotobiol.2015.10.015","article-title":"Photobiomodulation with 660-nm and 780-nm laser on activated J774 macrophage-like cells: effect on M1 inflammatory markers","volume":"153","author":"Fernandes","year":"2015","journal-title":"J. Photochem. Photobiol. B, Biol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1275","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/photonics6030077","article-title":"Photobiomodulation for Alzheimer\u2019s disease: has the light dawned?","volume":"6","author":"Hamblin","year":"2019","journal-title":"Photonics"},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb1280","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.7150\/thno.70756","article-title":"Non-invasive photobiomodulation treatment in an Alzheimer disease-like transgenic rat model","volume":"12","author":"Yang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2023.122257_bb1285","first-page":"S253","article-title":"Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer\u2019s disease","volume":"33 Suppl 1(0 1)","author":"Zhu","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.lfs.2023.122257_bb1290","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neurobiolaging.2016.10.003","article-title":"Low-level laser therapy for beta amyloid toxicity in rat hippocampus","volume":"49","author":"Lu","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"8","key":"10.1016\/j.lfs.2023.122257_bb1295","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/pho.2016.4238","article-title":"Effects of near-infrared light on cerebral bioenergetics measured with phosphorus magnetic resonance spectroscopy","volume":"35","author":"Mintzopoulos","year":"2017","journal-title":"Photomed. Laser Surg."},{"key":"10.1016\/j.lfs.2023.122257_bb1300","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jphotobiol.2014.07.021","article-title":"Absorption of monochromatic and narrow band radiation in the visible and near IR by both mitochondrial and non-mitochondrial photoacceptors results in photobiomodulation","volume":"140","author":"Passarella","year":"2014","journal-title":"J. Photochem. Photobiol. B, Biol."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb1305","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/php.12864","article-title":"Mechanisms and mitochondrial redox signaling in photobiomodulation","volume":"94","author":"Hamblin","year":"2018","journal-title":"Photochem. Photobiol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1310","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3233\/JAD-170585","article-title":"Mitochondria and mitochondrial cascades in Alzheimer\u2019s disease","volume":"62","author":"Swerdlow","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.lfs.2023.122257_bb1315","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.biocel.2014.05.009","article-title":"Delivering healthy mitochondria for the therapy of mitochondrial diseases and beyond","volume":"53","author":"Liu","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"26","key":"10.1016\/j.lfs.2023.122257_bb1320","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1073\/pnas.1404651111","article-title":"Transcellular degradation of axonal mitochondria","volume":"111","author":"Davis","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7613","key":"10.1016\/j.lfs.2023.122257_bb1325","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nature18928","article-title":"Transfer of mitochondria from astrocytes to neurons after stroke","volume":"535","author":"Hayakawa","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb1330","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3233\/JAD-190853","article-title":"Mitochondrial transfer ameliorates cognitive deficits, neuronal loss, and gliosis in Alzheimer\u2019s disease mice","volume":"72","author":"Nitzan","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb1335","doi-asserted-by":"crossref","first-page":"849","DOI":"10.7150\/ijbs.40886","article-title":"Improvement of cognitive and motor performance with mitotherapy in aged mice","volume":"16","author":"Zhao","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1340","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3233\/JAD-200686","article-title":"Mesenchymal stem cell-conditioned medium improves mitochondrial dysfunction and suppresses apoptosis in Okadaic acid-treated SH-SY5Y cells by extracellular vesicle mitochondrial transfer","volume":"78","author":"Zhang","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.lfs.2023.122257_bb1345","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3389\/fphar.2019.00902","article-title":"Mitochondria as potential targets in Alzheimer disease therapy: an update","volume":"10","author":"Cenini","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","article-title":"Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1355","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1582-4934.2010.01038.x","article-title":"Gene therapy in Alzheimer\u2019s disease - potential for disease modification","volume":"14","author":"Nilsson","year":"2010","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1360","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1002\/jcp.30064","article-title":"CRISPR\/Cas gene therapy","volume":"236","author":"Zhang","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.lfs.2023.122257_bb1365","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41551-021-00760-7","volume":"5","author":"Kaminski","year":"2021","journal-title":"CRISPR-based diagnostics. Nature biomedical engineering"},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1370","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/CS20200844","article-title":"Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer\u2019s disease","volume":"135","author":"Yu","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.lfs.2023.122257_bb1375","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jare.2021.07.001","article-title":"CRISPR\/Cas9 gene editing: new hope for Alzheimer\u2019s disease therapeutics","volume":"40","author":"Bhardwaj","year":"2022","journal-title":"J. Adv. Res."},{"issue":"5226","key":"10.1016\/j.lfs.2023.122257_bb1380","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1126\/science.7638621","article-title":"A familial Alzheimer\u2019s disease locus on chromosome 1","volume":"269","author":"Levy-Lahad","year":"1995","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.lfs.2023.122257_bb1385","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-1326-1-4","article-title":"Pathological and physiological functions of presenilins","volume":"1","author":"Vetrivel","year":"2006","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1390","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13024-018-0265-5","article-title":"iPSC-derived familial Alzheimer\u2019s PSEN2 N141I cholinergic neurons exhibit 89 mutation-dependent molecular pathology corrected by insulin signaling","volume":"13","author":"Moreno","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.lfs.2023.122257_bb1395","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.omtn.2018.03.007","article-title":"CRISPR\/Cas9 mediated disruption of the Swedish APP allele as a therapeutic approach for early-onset Alzheimer\u2019s disease","volume":"11","author":"Gy\u00f6rgy","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1400","doi-asserted-by":"crossref","first-page":"257","DOI":"10.14336\/AD.2017.0112","article-title":"Cerebral microvascular accumulation of tau oligomers in Alzheimer\u2019s disease and related Tauopathies","volume":"8","author":"Castillo-Carranza","year":"2017","journal-title":"Aging Dis."},{"issue":"41","key":"10.1016\/j.lfs.2023.122257_bb1405","doi-asserted-by":"crossref","first-page":"12029","DOI":"10.1002\/anie.201506030","article-title":"Self-assembled DNA nanoclews for the efficient delivery of CRISPR-Cas9 for genome editing","volume":"54","author":"Sun","year":"2015","journal-title":"Angew. Chem., Int. Ed. Engl."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1410","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1474-4422(13)70276-X","article-title":"Targeting the \u03b2 secretase BACE1 for Alzheimer's disease therapy","volume":"13","author":"Yan","year":"2014","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb1415","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JAD-140933","article-title":"Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer\u2019s disease","volume":"43","author":"Kumar","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb1420","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1425","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(11)70039-4","article-title":"AAV2-GAD gene therapy for advanced Parkinson\u2019s disease: a double-blind, sham-surgery controlled, randomised trial","volume":"10","author":"LeWitt","year":"2011","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb1430","first-page":"S94","article-title":"Caspase-6 knock-out using CRISPR\/Cas9 improves cognitive behavior in the 3xTg mouse model of Alzheimer\u2019s disease","volume":"20","author":"Offen","year":"2018","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1435","first-page":"122","article-title":"Therapeutic genome editing in cardiovascular diseases","volume":"4","author":"German","year":"2019","journal-title":"JACC: Basic Transl. Sci."},{"issue":"12","key":"10.1016\/j.lfs.2023.122257_bb1440","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200286","article-title":"Alzheimer\u2019s disease-like perturbations in HIV-mediated neuronal dysfunctions: understanding mechanisms and developing therapeutic strategies","volume":"10","author":"Jha","year":"2020","journal-title":"Open Biol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1445","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/nat.2018.0721","article-title":"Lipid nanoparticles enabling gene therapies: from concepts to clinical utility","volume":"28","author":"Kulkarni","year":"2018","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.lfs.2023.122257_bb1450","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.883459","article-title":"Current Progress of mitochondrial genome editing by CRISPR","volume":"13","author":"Yin","year":"2022","journal-title":"Front. Physiol."},{"issue":"11","key":"10.1016\/j.lfs.2023.122257_bb1455","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1517\/17425255.2010.530656","article-title":"Pharmacokinetic evaluation of idebenone","volume":"6","author":"Becker","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"11","key":"10.1016\/j.lfs.2023.122257_bb1460","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s00210-021-02161-8","article-title":"Coenzyme Q10 a mitochondrial restorer for various brain disorders","volume":"394","author":"Pradhan","year":"2021","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb1465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216385","article-title":"An old medicine as a new drug to prevent mitochondrial complex I from producing oxygen radicals","volume":"14","author":"Detaille","year":"2019","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb1470","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s40263-022-00907-3","article-title":"The potential of N-acetyl-L-cysteine (NAC) in the treatment of psychiatric disorders","volume":"36","author":"Bradlow","year":"2022","journal-title":"CNS Drugs"},{"issue":"7","key":"10.1016\/j.lfs.2023.122257_bb1475","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/FBP.0b013e3283123c98","article-title":"Antidepressant-like effects of N-acetyl-L-cysteine in rats","volume":"19","author":"Ferreira","year":"2008","journal-title":"Behav. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.lfs.2023.122257_bb1480","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jad.2011.06.005","article-title":"The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial","volume":"135","author":"Berk","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.lfs.2023.122257_bb1485","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1235241","article-title":"Targeting mitophagy for depression amelioration: a novel therapeutic strategy","volume":"17","author":"Xu","year":"2023","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1490","doi-asserted-by":"crossref","DOI":"10.1117\/1.NPh.3.3.031404","article-title":"Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis","volume":"3","author":"Cassano","year":"2016","journal-title":"Neurophotonics"},{"issue":"8","key":"10.1016\/j.lfs.2023.122257_bb1495","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1586\/14737175.7.8.961","article-title":"Laser treatment for stroke","volume":"7","author":"Lampl","year":"2007","journal-title":"Expert Rev. Neurother."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1500","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0304-3940(02)00159-3","article-title":"Effects of near-infra-red laser irradiation on adenosine triphosphate and adenosine diphosphate contents of rat brain tissue","volume":"323","author":"Mochizuki-Oda","year":"2002","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1505","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1089\/pho.2007.2064","article-title":"Ga-as (808 nm) laser irradiation enhances ATP production in human neuronal cells in culture","volume":"25","author":"Oron","year":"2007","journal-title":"Photomed. Laser Surg."},{"key":"10.1016\/j.lfs.2023.122257_bb1510","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1744-9081-5-46","article-title":"Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety","volume":"5","author":"Schiffer","year":"2009","journal-title":"Behav. Brain Funct. BBF"},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1515","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5978\/islsm.11-OR_01","article-title":"Reduction of interleukin-6 expression in human synoviocytes and rheumatoid arthritis rat joints by linear polarized near infrared light (Superlizer) irradiation","volume":"20","author":"Araki","year":"2011","journal-title":"Laser Ther."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb1520","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1089\/neu.2010.1745","article-title":"Low-level laser light therapy improves cognitive deficits and inhibits microglial activation after controlled cortical impact in mice","volume":"29","author":"Khuman","year":"2012","journal-title":"J. Neurotrauma"},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb1525","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/lsm.20886","article-title":"Radiant near infrared light emitting diode exposure as skin preparation to enhance photodynamic therapy inflammatory type acne treatment outcome","volume":"42","author":"Barolet","year":"2010","journal-title":"Lasers Surg. Med."},{"issue":"8","key":"10.1016\/j.lfs.2023.122257_bb1530","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1007\/s12035-017-0852-4","article-title":"Brain photobiomodulation therapy: a narrative review","volume":"55","author":"Salehpour","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2023.122257_bb1535","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jphotobiol.2017.04.014","article-title":"Biological effects and medical applications of infrared radiation","volume":"170","author":"Tsai","year":"2017","journal-title":"J. Photochem. Photobiol. B, Biol."},{"key":"10.1016\/j.lfs.2023.122257_bb1540","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.pnpbp.2019.04.010","article-title":"Mitochondrial transplantation attenuates lipopolysaccharide- induced depression-like behaviors","volume":"93","author":"Wang","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"17","key":"10.1016\/j.lfs.2023.122257_bb1545","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1089\/scd.2011.0691","article-title":"Vascular smooth muscle cells initiate proliferation of mesenchymal stem cells by mitochondrial transfer via tunneling nanotubes","volume":"21","author":"Vallabhaneni","year":"2012","journal-title":"Stem Cells Dev."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1550","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12929-018-0429-1","article-title":"Regenerative abilities of mesenchymal stem cells through mitochondrial transfer","volume":"25","author":"Paliwal","year":"2018","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1555","first-page":"88","volume":"30","author":"Han","year":"2018","journal-title":"Zhonghua wei zhong bing ji jiu yi xue"},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb1560","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3727\/096368915X689785","article-title":"Transferring Xenogenic mitochondria provides neural protection against ischemic stress in ischemic rat brains","volume":"25","author":"Huang","year":"2016","journal-title":"Cell Transplant."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1565","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12868-018-0480-6","article-title":"Altered Slc25 family gene expression as markers of mitochondrial dysfunction in brain regions under experimental mixed anxiety\/depression-like disorder","volume":"19","author":"Babenko","year":"2018","journal-title":"BMC Neurosci."},{"issue":"11","key":"10.1016\/j.lfs.2023.122257_bb1570","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41582-022-00715-9","article-title":"Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges","volume":"18","author":"Falabella","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb1575","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/pharmaceutics15020572","article-title":"Delivery systems for mitochondrial gene therapy: a review","volume":"15","author":"Faria","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2023.122257_bb1580","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.mito.2021.03.006","article-title":"Mitochondria-targeting therapeutic strategies in the treatment of depression","volume":"58","author":"G\u0142ombik","year":"2021","journal-title":"Mitochondrion"},{"key":"10.1016\/j.lfs.2023.122257_bb1585","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.585047","article-title":"The mitochondrial chaperone TRAP1 as a candidate target of oncotherapy","volume":"10","author":"Xie","year":"2021","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.lfs.2023.122257_bb1590","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1038\/s41418-022-01020-0","article-title":"The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation","volume":"29","author":"Cannino","year":"2022","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1595","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41556-022-01074-9","article-title":"Small heat shock proteins operate as molecular chaperones in the mitochondrial intermembrane space","volume":"25","author":"Adriaenssens","year":"2023","journal-title":"Nat. Cell Biol."},{"issue":"10","key":"10.1016\/j.lfs.2023.122257_bb1600","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrm3439","article-title":"Minimizing the damage: repair pathways keep mitochondrial DNA intact","volume":"13","author":"Kazak","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1605","doi-asserted-by":"crossref","first-page":"10897","DOI":"10.1038\/s41598-021-90316-1","article-title":"Generation of somatic mitochondrial DNA-replaced cells for mitochondrial dysfunction treatment","volume":"11","author":"Maeda","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.122257_bb1610","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.797265","article-title":"Targeting mitochondrial protein expression as a future approach for Cancer therapy","volume":"11","author":"Criscuolo","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2023.122257_bb1615","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fmolb.2020.00159","article-title":"Complex destabilization in the mitochondrial chaperonin Hsp60 leads to disease","volume":"7","author":"Rodriguez","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb1620","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb1625","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.3928\/00904481-20150203-10","article-title":"Antiepileptic drugs--a review","volume":"44","author":"Sankaraneni","year":"2015","journal-title":"Pediatr. Ann."},{"issue":"7","key":"10.1016\/j.lfs.2023.122257_bb1630","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJM199802123380704","article-title":"Risk of recurrent seizures after two unprovoked seizures","volume":"338","author":"Hauser","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2023.122257_bb1635","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1528-1167.2008.01451.x","article-title":"An evidence-based approach to the first seizure","volume":"49","author":"Wiebe","year":"2008","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb1640","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2023.122257_bb1645","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107966","article-title":"Mechanisms of action of currently used antiseizure drugs","volume":"168","author":"Sills","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2023.122257_bb1650","series-title":"Carbamazepine","author":"Maan","year":"2022"},{"key":"10.1016\/j.lfs.2023.122257_bb1655","series-title":"Lamotrigine","author":"Betchel","year":"2023"},{"key":"10.1016\/j.lfs.2023.122257_bb1660","series-title":"Ethosuximide","author":"Hanrahan","year":"2022"},{"key":"10.1016\/j.lfs.2023.122257_bb1665","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108884","article-title":"The novel dual-mechanism Kv7 potassium channel\/TSPO receptor activator GRT-X is more effective than the Kv7 channel opener 93 retigabine in the 6-Hz refractory seizure mouse model","volume":"203","author":"Bloms-Funke","year":"2022","journal-title":"Neuropharmacology"},{"issue":"7885","key":"10.1016\/j.lfs.2023.122257_bb1670","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41586-021-04082-1","article-title":"B cell-derived GABA elicits IL-10 + macrophages to limit anti-tumor immunity","volume":"599","author":"Zhang","year":"2021","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.lfs.2023.122257_bb1675","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1007\/s11064-014-1263-9","article-title":"The GABA synapse as a target for antiepileptic drugs: a historical overview focused on GABA transporters","volume":"39","author":"Schousboe","year":"2014","journal-title":"Neurochem. Res."},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb1680","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000524400","article-title":"Benzodiazepines remain important therapeutic options in psychiatric practice","volume":"91","author":"Dubovsky","year":"2022","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.lfs.2023.122257_bb1685","series-title":"Topiramate","author":"Fariba","year":"2023"},{"key":"10.1016\/j.lfs.2023.122257_bb1690","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.979725","article-title":"Felbamate for pediatric epilepsy-should we keep on using it as the last resort?","volume":"13","author":"Rabinowicz","year":"2022","journal-title":"Front. Neurol."},{"issue":"7915","key":"10.1016\/j.lfs.2023.122257_bb1695","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41586-022-04814-x","article-title":"Structural basis of GABA reuptake inhibition","volume":"606","author":"Motiwala","year":"2022","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1700","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/ph15040475","article-title":"Levetiracetam mechanisms of action: from molecules to systems","volume":"15","author":"Contreras-Garc\u00eda","year":"2022","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1705","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s40120-022-00402-3","article-title":"Brivaracetam as early add-on treatment in patients with focal seizures: a retrospective, multicenter, real-world study","volume":"11","author":"Lattanzi, S., Canafoglia, L., Canevini, M. P., Casciato, S., Cerulli Irelli, E., Chiesa, V., Dainese, F., De Maria, G., Didato, G., Di Gennaro, G., Falcicchio, G., Fanella, M., Ferlazzo, E., Gangitano, M., La Neve, A., Mecarelli, O., Montalenti, E., Morano, A., Piazza, F., Pizzanelli, C., \u2026 BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) Group","year":"2022","journal-title":"Neurol Ther."},{"key":"10.1016\/j.lfs.2023.122257_bb1710","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.864514","article-title":"Synaptic vesicle glycoprotein 2A: features and functions","volume":"16","author":"Rossi","year":"2022","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb1715","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nchembio.2287","article-title":"The pharmacological regulation of cellular mitophagy","volume":"13","author":"Georgakopoulos","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb1720","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jalz.2016.08.001","article-title":"DNP, mitochondrial uncoupling, and neuroprotection: a little dab\u2019ll do ya","volume":"13","author":"Geisler","year":"2017","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1725","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.bcp.2013.06.012","article-title":"Neurological and psychological applications of transcranial lasers and LEDs","volume":"86","author":"Rojas","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122257_bb1730","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.873496","article-title":"Mitochondrial photobiomodulation as a neurotherapeutic strategy for epilepsy","volume":"13","author":"Cardoso","year":"2022","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1735","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/pho.2015.9848","article-title":"Low-level light\/laser therapy versus photobiomodulation therapy","volume":"33","author":"Anders","year":"2015","journal-title":"Photomed. Laser Surg."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb1740","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s10439-011-0454-7","article-title":"The nuts and bolts of low-level laser (light) therapy","volume":"40","author":"Chung","year":"2012","journal-title":"Ann. Biomed. Eng."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1745","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bcp.2013.11.010","article-title":"Mitochondrial respiration as a target for neuroprotection and cognitive enhancement","volume":"88","author":"Gonzalez-Lima","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1011-1344(98)00219-X","article-title":"Primary and secondary mechanisms of action of visible to near-IR radiation on cells","volume":"49","author":"Karu","year":"1999","journal-title":"J. Photochem. Photobiol. B Biol."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1755","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/pho.2005.23.355","article-title":"Exact action spectra for cellular responses relevant to phototherapy","volume":"23","author":"Karu","year":"2005","journal-title":"Photomed. Laser Surg."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb1760","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1039\/b306126d","article-title":"Photobiological modulation of cell attachment via cytochrome c oxidase","volume":"3","author":"Karu","year":"2004","journal-title":"Photochem. Photobiol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb1765","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.brs.2021.02.011","article-title":"Transcranial laser stimulation: mitochondrial and cerebrovascular effects in younger and older healthy adults","volume":"14","author":"Saucedo","year":"2021","journal-title":"Brain Stimul."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1770","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s12035-021-02606-4","article-title":"Photobiomodulation improves the inflammatory response and intracellular signaling proteins linked to vascular function and cell survival in the brain of aged rats","volume":"59","author":"Dos Santos Cardoso","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2023.122257_bb1775","series-title":"Mechanisms for Low-Light Therapy III","first-page":"7","article-title":"The role of nitric oxide in low level light therapy","volume":"vol. 6846","author":"Hamblin","year":"2008"},{"issue":"8","key":"10.1016\/j.lfs.2023.122257_bb1780","doi-asserted-by":"crossref","DOI":"10.1002\/jbio.202000095","article-title":"Transcranial photobiomodulation attenuates pentylenetetrazole-induced status epilepticus in peripubertal rats","volume":"13","author":"Tsai","year":"2020","journal-title":"J. Biophotonics"},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1785","doi-asserted-by":"crossref","DOI":"10.1002\/jbio.202000287","article-title":"Repetitive transcranial photobiomodulation but not long-term omega-3 intake reduces epileptiform discharges in rats with stroke-induced epilepsy","volume":"14","author":"Vogel","year":"2021","journal-title":"J. Biophotonics"},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1790","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3390\/ijms24031969","article-title":"Mitochondrial transplantation in mitochondrial medicine: current challenges and future perspectives","volume":"24","author":"D\u2019Amato","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1795","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s12035-020-02175-y","article-title":"TRAK1-mediated abnormality of mitochondrial fission increases seizure susceptibility in temporal lobe epilepsy","volume":"58","author":"Wu","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1800","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ame2.12310","article-title":"Mitochondrial transplantation ameliorates hippocampal damage following status epilepticus","volume":"6","author":"Jia","year":"2023","journal-title":"Anim. Models Exp. Med."},{"issue":"7","key":"10.1016\/j.lfs.2023.122257_bb1805","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.7150\/thno.29400","article-title":"Mitochondrial transfer from bone marrow mesenchymal stem cells to motor neurons in spinal cord injury rats via gap junction","volume":"9","author":"Li","year":"2019","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1810","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/0271678X20928147","article-title":"Mitochondrial transfer from mesenchymal stem cells improves neuronal metabolism after oxidant injury in vitro: the role of Miro1","volume":"41","author":"Tseng","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"14","key":"10.1016\/j.lfs.2023.122257_bb1815","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4103\/1673-5374.121651","article-title":"Anti-epileptic effects of neuropeptide Y gene transfection into the rat brain","volume":"8","author":"Dong","year":"2013","journal-title":"Neural Regen. Res."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb1820","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.nurt.2009.01.004","article-title":"Adeno-associated virus vector-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity","volume":"6","author":"McCown","year":"2009","journal-title":"Neurotherapeutics"},{"issue":"12","key":"10.1016\/j.lfs.2023.122257_bb1825","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/gt.2014.82","article-title":"Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy","volume":"21","author":"Young","year":"2014","journal-title":"Gene Ther."},{"issue":"16","key":"10.1016\/j.lfs.2023.122257_bb1830","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1523\/JNEUROSCI.1143-18.2019","article-title":"Epilepsy gene therapy using an engineered potassium channel","volume":"39","author":"Snowball","year":"2019","journal-title":"J. Neurosci."},{"issue":"161","key":"10.1016\/j.lfs.2023.122257_bb1835","doi-asserted-by":"crossref","first-page":"161ra152","DOI":"10.1126\/scitranslmed.3004190","article-title":"Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy","volume":"4","author":"Wykes","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1840","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/brain\/awaa045","article-title":"In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy","volume":"143","author":"Colasante","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.lfs.2023.122257_bb1845","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.868531","article-title":"Gene and cell therapy for epilepsy: a mini review","volume":"15","author":"Shaimardanova","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb1850","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/jama.2015.120","article-title":"Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial","volume":"313","author":"Writing Group for the NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators, Kieburtz, K., Tilley, B. C., Elm, J. J., Babcock, D., Hauser, R., Ross, G. W., Augustine, A. H., Augustine, E. U., Aminoff, M. J., Bodis-Wollner, I. G., Boyd, J., Cambi, F., Chou, K., Christine, C. W., Cines, M., Dahodwala, N., Derwent, L., Dewey, R. B., Jr, Hawthorne, K., \u2026 Wills, A. M","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.lfs.2023.122257_bb1855","article-title":"Survival of dopaminergic Amacrine cells after near-infrared light treatment in MPTP-treated mice","volume":"2012","author":"Peoples","year":"2012","journal-title":"ISRN Neurol."},{"key":"10.1016\/j.lfs.2023.122257_bb1860","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s42466-019-0033-1","article-title":"An omics-based strategy using coenzyme Q10 in patients with Parkinson\u2019s disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial","volume":"1","author":"Prasuhn","year":"2019","journal-title":"Neurol. Res. Pract."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1865","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cmet.2022.02.001","article-title":"The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson\u2019s disease","volume":"34","author":"Brakedal","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.lfs.2023.122257_bb1870","doi-asserted-by":"crossref","first-page":"5577541","DOI":"10.1155\/2021\/5577541","article-title":"Effect of melatonin administration on mitochondrial activity and oxidative stress markers in patients with Parkinson\u2019s disease","volume":"2021","author":"Jim\u00e9nez-Delgado","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"8","key":"10.1016\/j.lfs.2023.122257_bb1875","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/mds.29450","article-title":"A double-blind, randomized, placebo-controlled trial of Ursodeoxycholic acid (UDCA) in Parkinson\u2019s disease","volume":"38","author":"Payne","year":"2023","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb1880","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/jamaneurol.2014.131","article-title":"A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit","volume":"71","author":"Parkinson Study Group QE3 Investigators, Beal, M. F., Oakes, D., Shoulson, I., Henchcliffe, C., Galpern, W. R., Haas, R., Juncos, J. L., Nutt, J. G., Voss, T. S., Ravina, B., Shults, C. M., Helles, K., Snively, V., Lew, M. F., Griebner, B., Watts, A., Gao, S., Pourcher, E., Bond, L., \u2026 Boyar, K","year":"2014","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb1885","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/jcph.1575","article-title":"Pharmacokinetics, safety, and tolerability of orally administered ursodeoxycholic acid in patients with Parkinson\u2019s disease-a pilot study","volume":"60","author":"Sathe","year":"2020","journal-title":"J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.lfs.2023.122257_bb1890","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1212\/01.wnl.0000238518.34389.12","article-title":"Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial","volume":"67","author":"Bender","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1895","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3233\/JPD-171203","article-title":"Simvastatin as a potential disease-modifying therapy for patients with Parkinson\u2019s disease: rationale for clinical trial, and current progress","volume":"7","author":"Carroll","year":"2017","journal-title":"J. Parkinsons Dis."},{"issue":"7","key":"10.1016\/j.lfs.2023.122257_bb1900","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archneur.64.7.nct60005","article-title":"Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease","volume":"64","author":"Storch, A., Jost, W. H., Vieregge, P., Spiegel, J., Greulich, W., Durner, J., M\u00fcller, T., Kupsch, A., Henningsen, H., Oertel, W. H., Fuchs, G., Kuhn, W., Niklowitz, P., Koch, R., Herting, B., Reichmann, H., & German Coenzyme Q(10) Study Group","year":"2007","journal-title":"Arch. Neurol."},{"issue":"11","key":"10.1016\/j.lfs.2023.122257_bb1905","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/mds.23148","article-title":"A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease","volume":"25","author":"Snow, B. J., Rolfe, F. L., Lockhart, M. M., Frampton, C. M., O'Sullivan, J. D., Fung, V., Smith, R. A., Murphy, M. P., Taylor, K. M., & Protect Study Group","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2023.122257_bb1910","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102434","article-title":"Idebenone does not inhibit disability progression in primary progressive MS","volume":"45","author":"Kosa","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1915","doi-asserted-by":"crossref","first-page":"58","DOI":"10.23736\/S1973-9087.17.04637-8","article-title":"High-intensity interval training combined with resistance training improves physiological capacities, strength and quality of life in multiple sclerosis patients: a pilot study","volume":"54","author":"Zaenker","year":"2018","journal-title":"Eur. J. Phys. Rehabil. Med."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb1920","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40263-023-00985-x","article-title":"Teriflunomide concentrations in cerebrospinal fluid and plasma in patients with multiple sclerosis: a pharmacokinetic study","volume":"37","author":"Lycke","year":"2023","journal-title":"CNS Drugs"},{"issue":"490","key":"10.1016\/j.lfs.2023.122257_bb1925","doi-asserted-by":"crossref","first-page":"eaao5563","DOI":"10.1126\/scitranslmed.aao5563","article-title":"Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects","volume":"11","author":"Klotz","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1930","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/1352458508099141","article-title":"Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis","volume":"15","author":"Broadley","year":"2009","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1935","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40035-023-00336-2","article-title":"Combined metabolic activators improve cognitive functions in Alzheimer\u2019s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial","volume":"12","author":"Yulug","year":"2023","journal-title":"Transl. Neurodegener."},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb1940","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/JCP.0000000000000938","article-title":"Evaluating the effect of coenzyme Q10 augmentation on treatment of bipolar depression: a double-blind controlled clinical trial","volume":"38","author":"Mehrpooya","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1945","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1590\/1516-4446-2018-0114","article-title":"Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial","volume":"41","author":"Ashton","year":"2019","journal-title":"Rev. Bras. de Psiquiatr. (Sao Paulo, Brazil\u202f: 1999)"},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1950","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/1516-4446-2013-1341","article-title":"Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression","volume":"37","author":"Dean","year":"2015","journal-title":"Rev. Bras. de Psiquiatr. (Sao Paulo, Brazil\u202f: 1999)"},{"key":"10.1016\/j.lfs.2023.122257_bb1955","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-94-024-1088-4_1","article-title":"TRP Channel classification","volume":"976","author":"Li","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb1960","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/hmg\/dds470","article-title":"MicroRNA-205 regulates the expression of Parkinson\u2019s disease-related leucine-rich repeat kinase 2 protein","volume":"22","author":"Cho","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb1965","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/bpa.12267","article-title":"MiR-124 regulates apoptosis and autophagy process in MPTP model of Parkinson\u2019s disease by targeting to Bim","volume":"26","author":"Wang","year":"2016","journal-title":"Brain Pathol. (Zurich, Switzerland)"},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb1970","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ajhg.2013.05.025","article-title":"miR-196a ameliorates phenotypes of Huntington disease in cell, transgenic mouse, and induced pluripotent stem cell models","volume":"93","author":"Cheng","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.lfs.2023.122257_bb1975","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1523\/JNEUROSCI.2035-19.2020","article-title":"Elevated TRPV4 levels contribute to endothelial damage and scarring in experimental spinal cord injury","volume":"40","author":"Kumar","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2023.122257_bb1980","first-page":"1512457","article-title":"Integrating TRPV1 receptor function with capsaicin psychophysics","volume":"2016","author":"Smutzer","year":"2016","journal-title":"Adv. Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb1985","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e16910","article-title":"TRP channels: role in neurodegenerative diseases and therapeutic targets","volume":"9","author":"Rather","year":"2023","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb1990","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12031-016-0828-2","article-title":"Neuroprotective role of MicroRNA-22 in a 6-Hydroxydopamine-induced cell model of Parkinson\u2019s disease via regulation of its target gene TRPM7","volume":"60","author":"Yang","year":"2016","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb1995","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/cells8010028","article-title":"Increasing the TRPM2 channel expression in human neuroblastoma SH-SY5Y cells augments the susceptibility to ROS-induced cell death","volume":"8","author":"An","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb2000","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12035-016-0338-9","article-title":"TRPM2 promotes neurotoxin MPP+\/MPTP-induced cell death","volume":"55","author":"Sun","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb2005","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1074\/jbc.M407384200","article-title":"TRPC1-mediated inhibition of 1-methyl-4-phenylpyridinium ion neurotoxicity in human SH-SY5Y neuroblastoma cells","volume":"280","author":"Bollimuntha","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.122257_bb2010","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70920","article-title":"TRPC3 and NALCN channels drive pacemaking in substantia nigra dopaminergic neurons","volume":"10","author":"Um","year":"2021","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb2015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.expneurol.2007.07.021","article-title":"Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson\u2019s disease: role of CB(1) and TRPV1 receptors","volume":"208","author":"Morgese","year":"2007","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb2020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.expneurol.2007.07.021","article-title":"Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson\u2019s disease: role of CB(1) and TRPV1 receptors","volume":"208","author":"Morgese","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2023.122257_bb2025","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.nbd.2013.10.008","article-title":"Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson\u2019s disease","volume":"62","author":"Gonz\u00e1lez-Aparicio","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb2030","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/fcp.12015","article-title":"Pharmacological blockade of TRPV1 receptors modulates the effects of 6-OHDA on motor and cognitive functions in a rat model of Parkinson\u2019s disease","volume":"27","author":"Razavinasab","year":"2013","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb2035","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.159","article-title":"Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson\u2019s disease","volume":"49","author":"Chung","year":"2017","journal-title":"Exp. Mol. Med."},{"issue":"3\u20134","key":"10.1016\/j.lfs.2023.122257_bb2040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainresbull.2012.07.001","article-title":"Transient receptor potential vanilloid subtype 1 contributes to mesencephalic dopaminergic neuronal survival by inhibiting microglia-originated oxidative stress","volume":"89","author":"Park","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.lfs.2023.122257_bb2045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.eplepsyres.2016.02.005","article-title":"Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy","volume":"122","author":"Carletti","year":"2016","journal-title":"Epilepsy Res."},{"issue":"8","key":"10.1016\/j.lfs.2023.122257_bb2050","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s10072-014-1689-5","article-title":"Involvement of central TRPV1 receptors in pentylenetetrazole and amygdala-induced kindling in male rats","volume":"35","author":"Shirazi","year":"2014","journal-title":"Neurol. Sci."},{"issue":"1\u20133","key":"10.1016\/j.lfs.2023.122257_bb2055","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejphar.2013.07.041","article-title":"Piperine exerts anti-seizure effects via the TRPV1 receptor in mice","volume":"714","author":"Chen","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb2060","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41419-019-1612-3","article-title":"TRPV4-induced inflammatory response is involved in neuronal death in pilocarpine model of temporal lobe epilepsy in mice","volume":"10","author":"Wang","year":"2019","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb2065","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41419-019-1612-3","article-title":"TRPV4-induced inflammatory response is involved in neuronal death in pilocarpine model of temporal lobe epilepsy in mice","volume":"10","author":"Wang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2023.122257_bb2070","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121871","article-title":"Amelioration of Parkinson\u2019s disease by pharmacological inhibition and knockdown of redox sensitive TRPC5 channels: focus on mitochondrial health","volume":"328","author":"Vaidya","year":"2023","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.lfs.2023.122257_bb2075","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3390\/pharmaceutics11090446","article-title":"Computational drug repurposing algorithm targeting TRPA1 Calcium Channel as a potential therapeutic solution for multiple sclerosis","volume":"11","author":"Mihai","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2023.122257_bb2080","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121871","article-title":"Amelioration of Parkinson\u2019s disease by pharmacological inhibition and knockdown of redox sensitive TRPC5 channels: focus on mitochondrial health","volume":"328","author":"Vaidya","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb2090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13024-017-0194-8","article-title":"TRPA1 channels promote astrocytic Ca2+ hyperactivity and synaptic dysfunction mediated by oligomeric forms of amyloid-\u03b2 peptide","volume":"12","author":"Bosson","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb2095","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1471-4159.2005.03396.x","article-title":"Amyloid beta-peptide(1-42) and hydrogen peroxide-induced toxicity are mediated by TRPM2 in rat primary striatal cultures","volume":"95","author":"Fonfria","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2023.122257_bb2100","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1038\/ncomms6318","article-title":"The key role of transient receptor potential melastatin-2 channels in amyloid-\u03b2-induced neurovascular dysfunction","volume":"5","author":"Park","year":"2014","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb2105","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1007\/s12035-016-9835-0","article-title":"The protective role of selenium on scopolamine-induced memory impairment, oxidative stress, and apoptosis in aged rats: the involvement of TRPM2 and TRPV1 channels","volume":"54","author":"Balaban","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2023.122257_bb2110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.brainres.2016.04.022","article-title":"Protective effect of transient receptor potential vanilloid subtype 1 (TRPV1) modulator, against behavioral, biochemical and structural damage in experimental models of Alzheimer\u2019s disease","volume":"1642","author":"Jayant","year":"2016","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb2115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172477","article-title":"Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats","volume":"12","author":"Xu","year":"2017","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb2120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JAD-121837","article-title":"Capsaicin ameliorates stress-induced Alzheimer\u2019s disease-like pathological and cognitive impairments in rats","volume":"35","author":"Jiang","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb2125","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1476-5381.2012.01889.x","article-title":"\u03b2-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-\u03b1, PPAR-\u03b3 and TRPV1, but not CB\u2081 or CB\u2082 receptors","volume":"166","author":"Benito","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122257_bb2130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuro.2014.01.001","article-title":"Involvement of TRPV4 channels in A\u03b2(40)-induced hippocampal cell death and astrocytic ca(2+) signalling","volume":"41","author":"Bai","year":"2014","journal-title":"Neurotoxicology"},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb2135","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bph.12315","article-title":"Endothelial TRPV4 channels mediate dilation of cerebral arteries: impairment and recovery in cerebrovascular pathologies related to Alzheimer\u2019s disease","volume":"170","author":"Zhang","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb2140","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cellsig.2004.09.005","article-title":"The overexpression of presenilin2 and Alzheimer\u2019s-disease-linked presenilin2 variants influences TRPC6-enhanced Ca2+ entry into HEK293 cells","volume":"17","author":"Lessard","year":"2005","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb2145","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3233\/JAD-121714","article-title":"Tetrahydrohyperforin increases adult hippocampal neurogenesis in wild-type and APPswe\/PS1\u0394E9 mice","volume":"34","author":"Abbott","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb2150","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/bpa.12069","article-title":"St. John\u2019s wort reduces beta-amyloid accumulation in a double transgenic Alzheimer\u2019s disease mouse model-role of P-glycoprotein","volume":"24","author":"Brenn","year":"2014","journal-title":"Brain Pathol. (Zurich, Switzerland)"},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb2155","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s11064-018-2696-3","article-title":"Pretreatment-Etidronate alleviates CoCl2 induced-SH-SY5Y cell apoptosis via decreased HIF-1\u03b1 and TRPC5 channel proteins","volume":"44","author":"Li","year":"2019","journal-title":"Neurochem. Res."},{"issue":"8","key":"10.1016\/j.lfs.2023.122257_bb2160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136255","article-title":"Acute treatment with a novel TRPC4\/C5 channel inhibitor produces antidepressant and anxiolytic-like effects in mice","volume":"10","author":"Yang","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb2165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191225","article-title":"Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice","volume":"13","author":"Just","year":"2018","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.lfs.2023.122257_bb2170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/FBP.0b013e3283095234","article-title":"Attenuation of anxiety-related behaviour after the antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus","volume":"19","author":"Santos","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122257_bb2175","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2210-11-6","article-title":"Differential effects of TRPV1 receptor ligands against nicotine-induced depression-like behaviors","volume":"11","author":"Hayase","year":"2011","journal-title":"BMC Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2023.122257_bb2180","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/10799893.2011.555914","article-title":"Topiramate modulates hippocampus NMDA receptors via brain Ca(2+) homeostasis in pentylentetrazol-induced epilepsy of rats","volume":"31","author":"Yilmaz","year":"2011","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.lfs.2023.122257_bb2185","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3906\/biy-1505-43","article-title":"Role of melatonin on calcium signaling and mitochondrial oxidativestress in epilepsy: focus on TRP channels","volume":"39","author":"Naz\u0131ro\u011flu","year":"2015","journal-title":"Turk. J. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122257_bb2190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0971-5916.154489","article-title":"Mitochondrial disorders: challenges in diagnosis & treatment","volume":"141","author":"Khan","year":"2015","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.lfs.2023.122257_bb2195","series-title":"Mitochondria-Targeted Antioxidants , an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases\u00a0: Perspectives and Limitations","author":"Fields","year":"2023"},{"key":"10.1016\/j.lfs.2023.122257_bb2200","series-title":"Resveratrol\u00a0: A Double-Edged Sword in Health Benefits","first-page":"1","author":"Salehi","year":"2018"},{"key":"10.1016\/j.lfs.2023.122257_bb2205","series-title":"Enhancing the Delivery of Resveratrol in Humans: If Low Bioavailability Is the Problem, What Is the Solution?","first-page":"17154","author":"Smoliga","year":"2014"},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb2210","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/HYPERTENSIONAHA.117.10787","article-title":"Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults","volume":"71","author":"Rossman","year":"2018","journal-title":"Hypertension (Dallas, Tex.\u202f: 1979)"},{"issue":"15","key":"10.1016\/j.lfs.2023.122257_bb2215","doi-asserted-by":"crossref","first-page":"12486","DOI":"10.3390\/ijms241512486","article-title":"Exploring molecular targets for mitochondrial therapies in neurodegenerative diseases","volume":"24","author":"Plascencia-Villa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.lfs.2023.122257_bb2220","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3390\/nu14050921","article-title":"Effects of creatine supplementation on brain function and health","volume":"14","author":"Forbes","year":"2022","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb2225","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/photonics6030077","article-title":"Photobiomodulation for Alzheimer\u2019s disease: has the light dawned?","volume":"6","author":"Hamblin","year":"2019","journal-title":"Photonics"},{"key":"10.1016\/j.lfs.2023.122257_bb2230","first-page":"1","article-title":"Preclinical studies of transcranial photobiomodulation in the neurological diseases","volume":"2021","author":"You","year":"2020","journal-title":"November"},{"issue":"7","key":"10.1016\/j.lfs.2023.122257_bb2235","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.3390\/cells10071827","article-title":"Mitotherapy: unraveling a promising treatment for disorders of the central nervous system and other systemic conditions","volume":"10","author":"Nascimento-Dos-Santos","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.lfs.2023.122257_bb2240","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41593-020-00778-1","article-title":"Gene-based therapies for neurodegenerative diseases","volume":"24","author":"Sun","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.lfs.2023.122257_bb2245","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fncel.2016.00219","article-title":"Promise and pitfalls of mitochondrial replacement for prevention and cure of heritable neurodegenerative diseases caused by deleterious mutations in mitochondrial DNA","volume":"10","author":"Paine","year":"2016","journal-title":"Front. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.lfs.2023.122257_bb2250","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.7150\/thno.21254","article-title":"Current strategies for brain drug delivery","volume":"8","author":"Dong","year":"2018","journal-title":"Theranostics"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523008925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523008925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T09:45:53Z","timestamp":1750239953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523008925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":449,"alternative-id":["S0024320523008925"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122257","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122257"}}